These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 27374222

  • 1. Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial.
    Pu S, Rodríguez-Pérez C, Ramprasath VR, Segura-Carretero A, Jones PJ.
    Vascul Pharmacol; 2016 Dec; 87():60-65. PubMed ID: 27374222
    [Abstract] [Full Text] [Related]

  • 2. DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.
    Jones PJ, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, Lamarche B, Couture P, Charest A, Baril-Gravel L, West SG, Liu X, Fleming JA, McCrea CE, Kris-Etherton PM.
    Am J Clin Nutr; 2014 Jul; 100(1):88-97. PubMed ID: 24829493
    [Abstract] [Full Text] [Related]

  • 3. Docosahexaenoic Acid Attenuates Cardiovascular Risk Factors via a Decline in Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Plasma Levels.
    Rodríguez-Pérez C, Ramprasath VR, Pu S, Sabra A, Quirantes-Piné R, Segura-Carretero A, Jones PJ.
    Lipids; 2016 Jan; 51(1):75-83. PubMed ID: 26620373
    [Abstract] [Full Text] [Related]

  • 4. High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans.
    Jones PJ, MacKay DS, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, Lamarche B, Couture P, Kris-Etherton PM, West SG, Liu X, Fleming JA, Hantgan RR, Rudel LL.
    Atherosclerosis; 2015 Feb; 238(2):231-8. PubMed ID: 25528432
    [Abstract] [Full Text] [Related]

  • 5. Effects of canola and high-oleic-acid canola oils on abdominal fat mass in individuals with central obesity.
    Liu X, Kris-Etherton PM, West SG, Lamarche B, Jenkins DJ, Fleming JA, McCrea CE, Pu S, Couture P, Connelly PW, Jones PJ.
    Obesity (Silver Spring); 2016 Nov; 24(11):2261-2268. PubMed ID: 27804268
    [Abstract] [Full Text] [Related]

  • 6. Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition.
    Pu S, Eck P, Jenkins DJ, Connelly PW, Lamarche B, Kris-Etherton PM, West SG, Liu X, Jones PJ.
    Br J Nutr; 2016 Mar 28; 115(6):1012-23. PubMed ID: 26806592
    [Abstract] [Full Text] [Related]

  • 7. Docosahexaenoic acid-enriched canola oil increases adiponectin concentrations: a randomized crossover controlled intervention trial.
    Baril-Gravel L, Labonté ME, Couture P, Vohl MC, Charest A, Guay V, Jenkins DA, Connelly PW, West S, Kris-Etherton PM, Jones PJ, Fleming JA, Lamarche B.
    Nutr Metab Cardiovasc Dis; 2015 Jan 28; 25(1):52-9. PubMed ID: 25240692
    [Abstract] [Full Text] [Related]

  • 8. Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT).
    Senanayake VK, Pu S, Jenkins DA, Lamarche B, Kris-Etherton PM, West SG, Fleming JA, Liu X, McCrea CE, Jones PJ.
    Trials; 2014 Apr 23; 15():136. PubMed ID: 24754911
    [Abstract] [Full Text] [Related]

  • 9. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P, Stenman UH, Gylling H.
    Clin Sci (Lond); 2015 Sep 23; 129(5):439-46. PubMed ID: 25857271
    [Abstract] [Full Text] [Related]

  • 10. Effect of consuming novel foods consisting high oleic canola oil, barley β-glucan, and DHA on cardiovascular disease risk in humans: the CONFIDENCE (Canola Oil and Fibre with DHA Enhanced) study - protocol for a randomized controlled trial.
    Ramprasath VR, Thandapilly SJ, Yang S, Abraham A, Jones PJ, Ames N.
    Trials; 2015 Oct 31; 16():489. PubMed ID: 26518870
    [Abstract] [Full Text] [Related]

  • 11. Impact of diet and exercise on proprotein convertase subtilisin/kexin 9: A mini-review.
    Saely CH, Drexel H.
    Vascul Pharmacol; 2016 Dec 31; 87():10-13. PubMed ID: 27746375
    [Abstract] [Full Text] [Related]

  • 12. A systematic review of high-oleic vegetable oil substitutions for other fats and oils on cardiovascular disease risk factors: implications for novel high-oleic soybean oils.
    Huth PJ, Fulgoni VL, Larson BT.
    Adv Nutr; 2015 Nov 31; 6(6):674-93. PubMed ID: 26567193
    [Abstract] [Full Text] [Related]

  • 13. Interactions between Obesity Status and Dietary Intake of Monounsaturated and Polyunsaturated Oils on Human Gut Microbiome Profiles in the Canola Oil Multicenter Intervention Trial (COMIT).
    Pu S, Khazanehei H, Jones PJ, Khafipour E.
    Front Microbiol; 2016 Nov 31; 7():1612. PubMed ID: 27777570
    [Abstract] [Full Text] [Related]

  • 14. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events.
    Ridker PM, Rifai N, Bradwin G, Rose L.
    Eur Heart J; 2016 Feb 07; 37(6):554-60. PubMed ID: 26508163
    [Abstract] [Full Text] [Related]

  • 15. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S, Xu RX, Guo YL, Zhang Y, Zhu CG, Sun J, Li JJ.
    Nutr Metab Cardiovasc Dis; 2015 Apr 07; 25(4):411-7. PubMed ID: 25466598
    [Abstract] [Full Text] [Related]

  • 16. Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics.
    Gauthier MS, Awan Z, Bouchard A, Champagne J, Tessier S, Faubert D, Chabot K, Garneau PY, Rabasa-Lhoret R, Seidah NG, Ridker PM, Genest J, Coulombe B.
    J Clin Lipidol; 2018 Apr 07; 12(4):1027-1038. PubMed ID: 29699916
    [Abstract] [Full Text] [Related]

  • 17. Diets Enriched with Conventional or High-Oleic Acid Canola Oils Lower Atherogenic Lipids and Lipoproteins Compared to a Diet with a Western Fatty Acid Profile in Adults with Central Adiposity.
    Bowen KJ, Kris-Etherton PM, West SG, Fleming JA, Connelly PW, Lamarche B, Couture P, Jenkins DJA, Taylor CG, Zahradka P, Hammad SS, Sihag J, Chen X, Guay V, Maltais-Giguère J, Perera D, Wilson A, Juan SCS, Rempel J, Jones PJH.
    J Nutr; 2019 Mar 01; 149(3):471-478. PubMed ID: 30773586
    [Abstract] [Full Text] [Related]

  • 18. Regulation of PCSK9 by nutraceuticals.
    Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A.
    Pharmacol Res; 2017 Jun 01; 120():157-169. PubMed ID: 28363723
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein profiles and serum peroxide levels of aged women consuming palmolein or oleic acid-rich sunflower oil diets.
    Cuesta C, Ródenas S, Merinero MC, Rodríguez-Gil S, Sánchez-Muniz FJ.
    Eur J Clin Nutr; 1998 Sep 01; 52(9):675-83. PubMed ID: 9756125
    [Abstract] [Full Text] [Related]

  • 20. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P, Ganz P, Ma Y, Scherzer R, Hur S, Weigel B, Grunfeld C, Deeks S, Wasserman S, Scott R, Hsue PY.
    J Am Heart Assoc; 2016 Apr 29; 5(5):. PubMed ID: 27130349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.